Infection Events in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim All-Case Post-Marketing Surveillance

被引：0

作者：

Tamura, Naoto ^{[1
]}

Kuwana, Masataka ^{[2
]}

Atsumi, Tatsuya ^{[3
]}

Takei, Syuji ^{[4
]}

Harigai, Masayoshi ^{[5
]}

Fujii, Takao ^{[6
]}

Matsuno, Hiroaki ^{[7
]}

Mimori, Tsuneyo ^{[8
]}

Momohara, Shigeki ^{[9
]}

Yamamoto, Kazuhiko ^{[10
]}

Takasaki, Yoshinari ^{[11
]}

Nomura, Kazuto ^{[12
]}

Endo, Yutaka ^{[12
]}

Hirose, Tomohiro ^{[12
]}

Morishima, Yosuke ^{[12
]}

Sugiyama, Naonobu ^{[12
]}

Yoshii, Noritoshi ^{[12
]}

Takagi, Michiaki ^{[13
]}

机构：

[1] Juntendo Univ, Tokyo, Japan

[2] Nippon Med Sch, Tokyo, Japan

[3] Hokkaido Univ, Sapporo, Hokkaido, Japan

[4] Med Ctr Children, Kagoshima, Japan

[5] Tokyo Womens Med Univ, Tokyo, Japan

[6] Wakayama Med Univ, Wakayama, Japan

[7] Matsuno Clin Rheumat Dis, Toyama, Japan

[8] Kyoto Univ, Kyoto, Japan

[9] Hakkeikai Inc Med Inst, Shizuoka, Japan

[10] Univ Tokyo, Tokyo, Japan

[11] Juntendo Univ, Fac Med, Juntendo Koshigaya Hosp, Saitama, Japan

[12] Pfizer Japan Inc, Tokyo, Japan

[13] Yamagata Univ, Fac Med, Yamagata, Japan

来源：

ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1516

引用

页数：3

共 50 条

[1] Malignancy in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim Analysis of All-Case Post-Marketing Surveillance
Tamura, Naoto
Kuwana, Masataka
Atsumi, Tatsuya
Takei, Syuji
Harigai, Masayoshi
Fujii, Takao
Matsuno, Hiroaki
Mimori, Tsuneyo
Momohara, Shigeki
Yamamoto, Kazuhiko
Takasaki, Yoshinari
Nomura, Kazuto
Endo, Yutaka
Hirose, Tomohiro
Morishima, Yosuke
Sugiyama, Naonobu
Yoshii, Noritoshi
Takagi, Michiaki
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[2] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
Tamura, N.
Kuwana, M.
Atsumi, T.
Takei, S.
Harigai, M.
Fujii, T.
Matsuno, H.
Mimori, T.
Momohara, S.
Yamamoto, K.
Nomura, K.
Endo, Y.
Sugiyama, N.
Hirose, T.
Morishima, Y.
Yoshii, N.
Takagi, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1408 - 1408
[3] Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
Mimori, Tsuneyo
Harigai, Masayoshi
Atsumi, Tatsuya
Kuwana, Masataka
Takei, Syuji
Tamura, Naoto
Fujii, Takao
Matsuno, Hiroaki
Momohara, Shigeki
Yamamoto, Kazuhiko
Kokubo, Takeshi
Endo, Yutaka
Sugiyama, Naonobu
Hirose, Tomohiro
Morishima, Yosuke
Yoshii, Noritoshi
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[4] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
Mimori, T.
Harigai, M.
Atsumi, T.
Kuwana, M.
Takei, S.
Tamura, N.
Fuji, T.
Matsuno, H.
Momohara, S.
Yamamoto, K.
Kokubo, T.
Endo, Y.
Sugiyama, N.
Hirose, T.
Morishima, Y.
Yoshii, N.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1200 - 1201
[5] Safety of baricitinib in Japanese patients with rheumatoid arthritis: the 2020 interim report from all-case post-marketing surveillance in clinical practice
Fujii, T.
Atsumi, T.
Okamoto, N.
Takahashi, N. T. N.
Tamura, N.
Nakajima, A.
Matsuno, H.
Tsujimoto, N.
Nishikawa, A.
Ishii, T.
Takeuchi, T.
Kuwana, M.
Takagi, M.
Larsson, E.
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 25 - 25
[6] Safety of Baricitinib in Patients with Rheumatoid Arthritis: Interim Report from All-Case Post-Marketing Study in Clinical Use
Atsumi, Tatsuya
Okamoto, Nami
Takahashi, Nobunori
Tamura, Naoto
Nakajima, Atsuo
Nakajima, Ayako
Fujii, Takao
Matsuno, Hiroaki
Takahashi, Yuko
Inui, Fumie
Tsujimoto, Naoto
Nishikawa, Atsushi
Ishii, Taeko
Takeuchi, Tsutomu
Kuwana, Masataka
Takagi, Michiaki
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[7] SAFETY OF BARICITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA): THE 2020 INTERIM REPORT FROM ALL-CASE POST MARKETING SURVEILLANCE IN CLINICAL PRACTICE
Fujii, T.
Atsumi, T.
Okamoto, N.
Takahashi, N.
Tamura, N.
Nakajima, A.
Matsuno, H.
Tsujimoto, N.
Nishikawa, A.
Ishii, T.
Takeuchi, T.
Kuwana, M.
Takagi, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1150 - 1150
[8] Safety of Baricitinib in Japanese Patients with Rheumatoid Arthritis (RA): The 2020 Interim Report from All-case Post Marketing Surveillance in Clinical Practice
Fujii, Takao
Atsumi, Tatsuya
Okamoto, Nami
Takahashi, Nobunori
Tamura, Naoto
Nakajima, Atsuo
Nakajima, Ayako
Matsuno, Hiroaki
Tsujimoto, Naoto
Nishikawa, Atsushi
Ishii, Taeko
Takeuchi, Tsutomu
Kuwana, Masataka
Takagi, Michiaki
[J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3489 - 3490
[9] All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis
Ogura, Takashi
Azuma, Arata
Inoue, Yoshikazu
Taniguchi, Hiroyuki
Chida, Kingo
Bando, Masashi
Niimi, Yuka
Kakutani, Shinichi
Suga, Moritaka
Sugiyama, Yukihiko
Kudoh, Shoji
Nukiwa, Toshihiro
[J]. RESPIRATORY INVESTIGATION, 2015, 53 (05) : 232 - 241
[10] Safety Profile of Nivolumab in Japanese NSCLC Pts: Interim Results from Post-marketing All-Case Surveillance in Japan
Genma, Akihiko
Nakanishi, Yoichi
Nakagawa, Kazuhiko
Yamamoto, Nobuyuki
Saito, Takeshi
Tahara, Yasuhiro
Ohe, Yuichiro
[J]. ANNALS OF ONCOLOGY, 2017, 28

← 1 2 3 4 5 →